Skip to Navigation Skip to Search Skip to Content
Search All Centers

ASH 2017 Myeloma Roundtable: Game-Changing Tools in Myeloma

Published on December 14, 2017

Will flow be the method used for myeloma treatment in the long term?  Does transplant still have a role in myeloma? Will liquid biopsies replace bone marrow biopsies? At the 2017 America Society of Hematology (ASH) annual meeting, a roundtable of esteemed myeloma experts, including Dr. Carol Ann Huff from Johns Hopkins University School of Medicine, Dr. Sagar Lonial of Emory University School of Medicine and Dr. Suzanne Lentzsch from New York Presbyterian Hospital/Columbia University Medical Center, weigh in on the breaking news and the expansion of the treatment armamentarium in and implications for different disease status. Host Jenny Ahlstrom, President and Founder of Myeloma Crowd, moderates this discussion and summarizes through the patient lens. Watch now as the myeloma experts discuss forthcoming game-changing tools in myeloma.

Produced by Patient Power. We thank you to thank AbbVie, Inc., Celgene and Takeda Oncology for their support.

 

Featuring

Sponsors

Patient Empowerment Network

You might also like